Category: Clinical Trial
Clinical Trial market research reports by GlobalData
-
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Human Immunodeficiency Virus (HIV) Tests Pipeline Report including Stages of D ... Read More
-
Autism Spectrum Disorder (ASD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Autism Spectrum Disorder (ASD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in ASD therapeutics. There will be over 9.8 million diagnosed prevalent cases of ASD i ... Read More
-
Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2029
Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2029 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides ... Read More
-
Alcohol Use Disorder (AUD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Alcohol Use Disorder (AUD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AUD therapeutics. There will be 746 million total prevalent cases of AUD in 2023 in the ... Read More
-
Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Human Papillomavirus (HPV) Vaccines Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HPV Vaccines therapeutics. There will be more than 33 million vaccinations in ... Read More
-
Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Ewing Sarcoma therapeutics. There will be only 9,457 diagnosed prevalent cases of ES in 2023 in the ... Read More
-
Atrial Fibrillation Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032
Atrial Fibrillation Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032 Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, Canada) and provides an ... Read More
-
Venous Thromboembolism Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032
Venous Thromboembolism Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Exce ... Read More
-
Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status ... Read More
-
Choroidal Neovascularization Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Choroidal Neovascularization Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Choroidal Neovascularization Clinical Trial Analysis by Trial Phase, Trial Status, Trial Coun ... Read More
-
Sicca Syndrome (Sjogren) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Sicca Syndrome (Sjogren) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Sicca Syndrome (Sjogren) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End ... Read More
-
Von Willebrand Disease (vWD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Von Willebrand Disease (vWD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Von Willebrand Disease (vWD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Coun ... Read More
-
Frozen Shoulder Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Frozen Shoulder Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Frozen Shoulder Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End ... Read More
-
Schizophrenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Schizophrenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Schizophrenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponso ... Read More
-
Ulcerative Colitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Ulcerative Colitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Ulcerative Colitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Stat ... Read More
-
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) ... Read More
-
Systemic Lupus Erythematosus Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Systemic Lupus Erythematosus Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Systemic Lupus Erythematosus Clinical Trial Analysis by Trial Phase, Trial Status, Trial Coun ... Read More
-
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Co ... Read More
-
Pneumococcal Vaccines (PV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Pneumococcal Vaccines (PV) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PV therapeutics. There will be more than 148 million vaccinations for PV in the adult p ... Read More
-
Reflux Esophagitis (Gastroesophageal Reflux Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Reflux Esophagitis (Gastroesophageal Reflux Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in GERD therapeutics. There will be more than 300 million preval ... Read More
-
Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Mpox (Monkeypox) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in mpox therapeutics. In the 10 pharmaceutical markets covered in GlobalData’s epidemiology fact she ... Read More
-
Vertigo Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Vertigo Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Vertigo Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and To ... Read More
-
Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Renal Cell Carcinoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, S ... Read More
-
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Narcolepsy therapeutics. There will be more than 900,000 diagnosed prevalent cases of narcolepsy in 202 ... Read More
-
Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial S ... Read More
Research Assistance
